Physiological and Eating-behavioral Responses to Viewing Sensory-specific Food Pictures
FOODPIC
1 other identifier
interventional
25
1 country
1
Brief Summary
The overall objective of the research project is to characterize the consequences of digital food stimuli exposure on eating behavior. Specifically, we aim to study cephalic phase physiology, food choice and quantity, as well as post-ingestive sensations in response to viewing sensory-specific food pictures. Furthermore, we want to examine whether these outcomes depend on sweet taste liking, as determined by FGF21 concentrations in the blood and the phenotypical Sweet Taste Liker Test. Section 2.1 lists the primary hypotheses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2023
CompletedFirst Submitted
Initial submission to the registry
January 19, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2023
CompletedAugust 15, 2023
August 1, 2023
5 months
January 19, 2023
August 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pancreatic polypeptide concentrations (pg/ml)
Assessed from blood samples in fasted state. Mixed models repeated measures comparison with subsequent post hoc testing.
Change against baseline (t = -15, 0 minutes) at t = 2, 4, 6, 8, 10, 15, 30 minutes, compared between visits (at least one week between each visit)
Secondary Outcomes (17)
Hunger (self-reported, VAS)
Baseline (t = -15, 0 minutes) vs. after picture viewing (t = 15 minutes) vs. after breakfast consumption (t = 45 minutes), between-visit differences in differences (at least one week between each visit)
Desire to eat something (self-reported, VAS)
Baseline (t = -15, 0 minutes) vs. after picture viewing (t = 15 minutes) vs. after breakfast consumption (t = 45 minutes), between-visit differences in differences (at least one week between each visit)
Desire for something sweet (self-reported, VAS)
Baseline (t = -15, 0 minutes) vs. after picture viewing (t = 15 minutes) vs. after breakfast consumption (t = 45 minutes), between-visit differences in differences (at least one week between each visit)
Desire for something salty (self-reported, VAS)
Baseline (t = -15, 0 minutes) vs. after picture viewing (t = 15 minutes) vs. after breakfast consumption (t = 45 minutes), between-visit differences in differences (at least one week between each visit)
Desire for something fatty (self-reported, VAS)
Baseline (t = -15, 0 minutes) vs. after picture viewing (t = 15 minutes) vs. after breakfast consumption (t = 45 minutes), between-visit differences in differences (at least one week between each visit)
- +12 more secondary outcomes
Study Arms (3)
Sweet Food (SW)
EXPERIMENTALExposure to pictures of sweet food.
Savoury Food (SA)
EXPERIMENTALExposure to pictures of savoury food.
Non-Food (NF)
EXPERIMENTALExposure to pictures of non-food items.
Interventions
Participants are shown pictures for 15 minutes; 50 images in total, each shown for 6 seconds, and 3 times in total.
Eligibility Criteria
You may qualify if:
- Normal or corrected-to-normal vision and no color-blindness
- Danish understanding
You may not qualify if:
- Regular smoking
- Dietary constraints, e.g., vegan/vegetarian, gluten or lactose intolerance, allergies
- For women: pregnancy / planned pregnancy (within the study period) / lactating
- Unable to understand the informed consent and the study procedures
- Self-reported history of an eating disorder in the past 3 years
- Uncontrolled medical issues, e.g.including, cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, GI or psychiatric disease, diabetes or other endocrine diseases, immunosuppression
- Current treatment with medication or medical devices significantly affecting glucose metabolism, appetite, or energy balance
- Current treatment with antidepressants
- Bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Steno Diabetes Center Copenhagenlead
- University of Aarhuscollaborator
Study Sites (1)
Steno Diabetes Center Copenhagen
Herlev, 2730, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristine Færch, PhD
Steno Diabetes Center Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants will be aware of the study visit assignment during the study visit when exposed to the experimental stimuli, but not beforehand. Investigators will be aware also before the study visit.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2023
First Posted
February 8, 2023
Study Start
January 17, 2023
Primary Completion
June 29, 2023
Study Completion
June 29, 2023
Last Updated
August 15, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share